Concepedia

Author

Guillermo Villa

Amgen (Switzerland)ORCID

Also Known As

G Villa, G. VILLA, G. Villa, Guillermo Sarmiento Villa, Guillermo Villa, R. Gatti, Villa, Guilia, Villa, Guillermo

136

Publications

1.4K

Citations

21

H-Index

29

Concepts

All Affiliations

Amgen (Switzerland)Amgen (United States)University of SheffieldKarolinska InstitutetSwedish Institute for Health Economics
GV

About

Guillermo Villa is an author at Amgen (Switzerland) specializing in medicine, pharmacotherapy, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

119

2

Public Health

2

2

87

3

Epidemiology

2

2

71

4

Engineering

1

1

12

5

Health Policy

1

1

52

Guillermo Villa

×

27

Publications

1.1K

Citations

19

H-Index

YearCitations

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

Gregg C. Fonarow, Anthony Keech, Terje R. Pedersen,

JAMA Cardiology

2017

143

Cost analysis of the Spanish renal replacement therapy programme

Guillermo Villa, Ana Rodríguez–Carmona, L Fernández-Ortiz,

Nephrology Dialysis Transplantation

2011

87

Cost‐Effectiveness of<scp>LDL</scp>‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Guillermo Villa, Gregg C. Fonarow, Mickael Löthgren,

Clinical Cardiology

2016

86

Updated Cost-effectiveness Analysis of Evolocumab in Patients With Very High-risk Atherosclerotic Cardiovascular Disease

Gregg C. Fonarow, Ben van Hout, Guillermo Villa,

JAMA Cardiology

2019

83

Estimated burden of cardiovascular disease and value-based price range for evolocumab in a high-risk, secondary-prevention population in the US payer context

Peter P. Tóth, Mark D. Danese, Guillermo Villa,

Journal of Medical Economics

2017

60

Estimating the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective

Richard B. Lipton, Alan Brennan, Stephen Palmer,

Journal of Medical Economics

2018

60

Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain.

Giuliano Mariani, Guillermo Villa, P F Rossettin,

PubMed

1999

56

Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain

Guillermo Villa, Mickael Löthgren, Lucie Kutikova,

Clinical Therapeutics

2017

52

Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems

Marc Miravitlles, Alicia Huerta, José Alberto Fernández-Villar,

Health and Quality of Life Outcomes

2014

47

Cardiovascular event rates in a high atherosclerotic cardiovascular disease risk population: estimates from Swedish population-based register data

Maria Lindh, Jonas Banefelt, Kathleen M. Fox,

European Heart Journal - Quality of Care and Clinical Outcomes

2019

44

Page 1